Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Morphosys AG ADR’s current trading price is -19.84% away from its 52-week high, while its distance from the 52-week low is 119.24%. The stock’s price range during this period has varied between $3.17 and $8.67. The company, active in the Healthcare sector, saw a trading volume of around 1.1 million for the day, considerably higher average daily volume of 0.26 million observed over the last three months.
Morphosys AG ADR (MOR) has a current stock price of $6.95. During the previous trading session, the stock witnessed a notable rise, reaching a high of $7.5975 after opening at $7.41. The stock’s low for the day was $6.92, and it eventually closed at $7.48.
Morphosys AG ADR’s stock has had a calm market performance. The 1-year high for the company’s stock was $8.67 on 07/20/23, and the lowest price during the same period was recorded at $3.17 on 12/28/22.
How Financial Performance Impacts Market Capitalization
Morphosys AG ADR (MOR) has experienced a quarterly decline of -10.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 949.93M and boasts a workforce of 647 employees.
Decoding Analysts’ Ratings for Morphosys AG ADR
As of right now, 7 analysts are rating Morphosys AG ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.47, with a change in price of -0.45. Similarly, Morphosys AG ADR recorded 248,754 in trading volume during the last 100 days, posting a change of -6.08%.
How MOR’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for MOR stands at 8.88. Similarly, the long-term debt-to-equity ratio is also 8.71.
MOR Stock Stochastic Average
As of today, the raw stochastic average of Morphosys AG ADR over the past 50 days is 40.85%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 19.60%. Additionally, the Stochastic %K and %D values for the company were 32.66% and 42.93%, respectively, over the past 20 days.
MOR Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price gain of 94.13% this year. Over the last six months, there has been a weaker performance of 16.81%. The price of MOR fallen by 2.36% during the last 30 days period. For the last 5-days stocks have slided -15.86%.